Avantax Advisory Services, Inc. Adma Biologics, Inc. Transaction History

Avantax Advisory Services, Inc.

$15.6 Billion
Q4 2024

A detailed history of Avantax Advisory Services, Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 106,373 shares of ADMA stock, worth $2.22 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

106,373

Previous 98,264 8.25%

Holding current value

$2.22 Million

Previous $1.96 Million 7.13%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	BUY	$15.62 - $22.62 $126,662 - $183,425	8,109 Added 8.25%	106,373 $1.82 Million
Q3 2024 Nov 13, 2024	SELL	$11.21 - $20.03 $88,435 - $158,016	-7,889 Reduced 7.43%	98,264 $1.96 Million
Q2 2024 Aug 09, 2024	BUY	$5.98 - $11.18 $1,094 - $2,045	183 Added 0.17%	106,153 $1.19 Million
Q3 2023 Nov 07, 2023	SELL	$3.47 - $4.61 $2,255 - $2,996	-650 Reduced 0.61%	105,970 $379,000
Q2 2023 Aug 11, 2023	SELL	$3.12 - $4.22 $21,840 - $29,540	-7,000 Reduced 6.16%	106,620 $393,000
Q1 2023 Apr 28, 2023	SELL	$3.01 - $3.87 $40,635 - $52,245	-13,500 Reduced 10.62%	113,620 $376,000
Q4 2021 Jan 24, 2022	BUY	$1.09 - $1.66 $59,950 - $91,300	55,000 Added 76.26%	127,120 $179,000
Q3 2021 Oct 21, 2021	SELL	$1.13 - $1.65 $84,422 - $123,271	-74,710 Reduced 50.88%	72,120 $81,000
Q2 2021 Jul 29, 2021	SELL	$1.51 - $2.07 $60 - $82	-40 Reduced 0.03%	146,830 $235,000
Q1 2021 May 13, 2021	BUY	$1.67 - $2.95 $58,450 - $103,250	35,000 Added 31.29%	146,870 $260,000
Q4 2020 Jan 22, 2021	SELL	$1.8 - $2.56 $85,500 - $121,600	-47,500 Reduced 29.8%	111,870 $219,000
Q3 2020 Oct 14, 2020	BUY	$2.04 - $3.74 $14,932 - $27,376	7,320 Added 4.81%	159,370 $383,000
Q2 2020 Aug 06, 2020	SELL	$2.42 - $3.29 $48,400 - $65,800	-20,000 Reduced 11.62%	152,050 $445,000
Q1 2020 Apr 30, 2020	BUY	$1.5 - $4.59 $55,500 - $169,830	37,000 Added 27.4%	172,050 $495,000
Q2 2019 Aug 06, 2019	BUY	$3.52 - $5.24 $123,200 - $183,400	35,000 Added 34.98%	135,050 $523,000
Q1 2019 May 13, 2019	BUY	$2.61 - $4.35 $91,350 - $152,250	35,000 Added 53.8%	100,050 $379,000
Q4 2018 Feb 13, 2019	BUY	$2.17 - $6.12 $141,158 - $398,106	65,050 New	65,050 $156,000

Others Institutions Holding ADMA

# of Institutions

342

Shares Held

181M

Call Options Held

1.72M

Put Options Held

846K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $4.11B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.

Account

Avantax Advisory Services, Inc. Adma Biologics, Inc. Transaction History